Evidence map›Paper›PMID 28370322›Full record

ArticleEnvironmental and molecular mutagenesis2017

Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay.

Steven M Bryce, Derek T Bernacki, Jeffrey C Bemis, Richard A Spellman, Maria E Engel, Maik Schuler, Elisabeth Lorge, Pekka T Heikkinen, Ulrike Hemmann, Véronique Thybaud and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Environmental and molecular mutagenesis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Transferability and Reproducibility of the HepaRG CometChip Assay.Environmental and molecular mutagenesis · 2025
    Article
  5. Critical Evaluation of Methods for the Identification of Aneugens.Environmental and molecular mutagenesis · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. In vitro human cell-based aneugen molecular mechanism assay.Environmental and molecular mutagenesis · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 6 countries.

Steven M BryceLitron Laboratories, Rochester, New York.
Derek T BernackiLitron Laboratories, Rochester, New York.
Jeffrey C BemisLitron Laboratories, Rochester, New York.
Richard A SpellmanPfizer Worldwide Research and Development, Groton, Connecticut.
Maria E EngelPfizer Worldwide Research and Development, Groton, Connecticut.
Maik SchulerPfizer Worldwide Research and Development, Groton, Connecticut.
Elisabeth LorgeServier Group, Gidy, France.
Pekka T HeikkinenOrion Pharma, Espoo, Finland.
Ulrike HemmannSanofi-Aventis Deutschland GmbH, Frankfurt, Germany.
Véronique ThybaudSanofi, Vitry-sur-Seine, France.
Sabrina WildeBayer AG, Berlin, Germany.
Nina QueisserBayer AG, Berlin, Germany.
Andreas SutterBayer AG, Berlin, Germany.
Andreas ZellerRoche Pharma Research and Early Development, Basel, Switzerland.
Melanie GuérardRoche Pharma Research and Early Development, Basel, Switzerland.
David KirklandKirkland Consulting, Tadcaster, United Kingdom.
Stephen D DertingerLitron Laboratories, Rochester, New York.
Litron Laboratories (United States) · USBayer (Germany) · DEPfizer (United States) · USRoche (Switzerland) · CHLancaster University · GBOrion Corporation (Finland) · FISanofi (France) · FRSanofi (Germany) · DEServier (France) · FR

Funding

Biomarker Matrix for Genotoxicity Mode of ActionR44ES024039 · NIEHS · LITRON LABORATORIES, LTD. · PI BEMIS, JEFFREY C, DERTINGER, STEPHEN D · 2014 to 2016
$1.1M
NIEHS NIH HHS R44 ES024039
6 · The paper itself

Abstract

We previously described a multiplexed in vitro genotoxicity assay based on flow cytometric analysis of detergent-liberated nuclei that are simultaneously stained with propidium iodide and labeled with fluorescent antibodies against p53, γH2AX, and phospho-histone H3. Inclusion of a known number of microspheres provides absolute nuclei counts. The work described herein was undertaken to evaluate the interlaboratory transferability of this assay, commercially known as MultiFlow

Indexed as

DNA DamageLaboratoriesAneugensAnimalsCell Culture TechniquesFlow CytometryHistonesHumansLogistic ModelsMutagenicity TestsMutagensPhosphorylationPilot ProjectsReproducibility of ResultsRoboticsSensitivity and SpecificityAneugensH2AX protein, humanHistonesMutagensTumor Suppressor Protein p53DNA damageH2AXmode of actionp53phospho-histone H3

Identifiers

PMID28370322
PMCPMC5436310
OpenAlexW2600915513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.